Ischemia and hepatic reperfusion: Is it possible to reduce hepatic alterations?

Microsurgery

Volumn 23, Issue 5, 2003, Pages 458-460

  Lanteri, Raffaele ^a   Greco, Raffaele ^a   Licitra, Edelweiss ^a   Di Benedetto, Fabrizio ^a   Li Destri, Giovanni ^a   Di Cataldo, Antonio ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BILIRUBIN; CANAVANINE; LIVER ENZYME; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HEPATIC ARTERY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER RESECTION; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION; REPERFUSION INJURY; TREATMENT OUTCOME;

ANIMALS; ARGININE; CANAVANINE; LIVER DISEASES; MODELS, ANIMAL; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0142182579     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10170     Document Type: Conference Paper

References (14)

1. Hines IN, Kawachi S, Hirohisa H, Pavlick KP, Hoffman JM, Bharwani S, Wolf RE, Grisham MB. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002;234:229-237.
2. Lichman SN, Lemaster JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 1999;19:171-187.
3. Meguro M, Katsuramaki T, Nagayama M, Kimura H, Isobe M, Kimura Y, Matsuno T, Nui A, Hirata K. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 2002;73:1439-1446.
4. Liu P, Xu B, Spokas E, Lai PS, Wong PY. Role of endogenous nitric oxide in TNF-alpha and IL-1 beta generation in hepatic ischemia-reperfusion. Shock 2000;13:217.
5. Hsu CM, Wang JS, Liu CH, Chen LW. Kupffer cells protect liver from ischemia-reperfusion injury by and inducible nitric oxide synthase-dependent mechanism. Shock 2002;17:280-285.
6. Chen HM, Chen JC, Shyr MH. Neutrophil elastase inhibitor (ONO-5046) attenuates reperfusion-induced hepatic microcirculatory derangement, energy depletion and lipid peroxidation in rats. Shock 2002;12:462-467.
7. Uhlmann D, Uhlmann S, Spiegel HU. Endothelin/nitric oxide balance influences hepatic ischemia-reperfusion injury. J Cardiovasc Pharmacol 2000;36:212-214.
8. Mustafa SB, Flickinger BD, Olson MS. Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. Hepatology 1999;30:1206.
9. Vos TA, Goor H, Tuyt L. Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 1999;29:421.
10. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998;275:2191.
11. Fukahara K, Murakami A, Watanabe G. Inhaled nitric oxide after lung ischemia-reperfusion; effect on hemodynamics and oxygen free radical scavenger system. Eur J Cardiothorac Surg 1997;11:343.
12. Isobe M, Katsuramaki T, Hirata K. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999;68:803.
13. Uhlmann D, Uhlmann S, Palmes D, Spigel HU. Endothelin receptor blockade as a therapeutic strategy in ameliorating postischemic damage to the liver microcirculation. J Cardiovasc Pharmacol 2000;36:351-353.
14. Lee VC, Johnson ML, Baust J, Laubach VE, Watkins SC, Billiar TR. The role of iNOS in liver ischemia-reperfusion injury. Shock 2001;16:355-360.